Schedule 13G ownership disclosure
Amryt Pharma plc
Security class unavailable · CUSIP: 3217L1061
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 110,824,152
- Percent of class
- 6.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-21-000111
- Form type
- SC 13G
- Filer
- Amryt Pharma plc
- CIK
- CIK 1783010
- Filed
- Feb 12, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership